Form 4: Cytokinetics Director Muna Bhanji Sells 2,000 Shares
SEC Form 4 Filing
Director Muna Bhanji sold 2,000 shares of Cytokinetics Inc. (CYTK) at a price of $52.07 on June 10, 2024.
Summary
- On June 10, 2024, Muna Bhanji, a director of Cytokinetics Inc. (CYTK), sold 2,000 shares of common stock.
- The transaction was executed at a price of $52.07 per share.
- Following the transaction, Muna Bhanji directly owns 17,631 shares of Cytokinetics Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it simply reports the sale of shares by a company director.
Industry Context
Insider sales are a common occurrence and can be for various reasons, including diversification or personal financial planning. It's important to consider the overall context and not solely rely on insider transactions to make investment decisions.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, but it is a relatively small transaction and may not have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of transaction: Muna Bhanji sold 2,000 shares of Cytokinetics Inc. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.